Table 1 Clinical features of the studied patients with hepatocellular carcinoma.
Number | Age | Gender | Pathological Stage | HBV infection |
|---|---|---|---|---|
Case #1 | 57 | male | III | HBV+ (93.57) |
Case #2 | 61 | male | II | HBV+ (>225) |
Case #3 | 75 | male | I | −(0.001) |
Case #4 | 40 | male | III | HBV+ (>250) |
Case #5 | 50 | male | I~II | HBV+ (31.83) |
Case #6 | 48 | male | I | HBV+ (>225) |
Case #7 | 42 | male | II~III | HBV+ (9.102) |
Case #8 | 53 | male | III | HBV+ (11.687) |
Case #9 | 68 | male | II | −(0.001) |
Case #10 | 45 | male | III | HBV+ (>250) |
Case #11 | 54 | male | III | HBV+ (>250) |
Case #12 | 66 | male | II~III | HBV+ (9.102) |
Case #13 | 46 | male | II | −(0.001) |
Case #14 | 61 | male | I | HBV+ (133.69) |
Case #15 | 53 | male | III | HBV+ (11.687) |
Case #16 | 49 | male | II | −(0.001) |
Case #17 | 55 | male | I | −(0.001) |
Case #18 | 74 | male | I | −(0.001) |
Case #19 | 63 | male | II | HBV+ (72.519) |
Case #20 | 60 | female | I | HBV+ (250) |
Case #21 | 66 | male | III | HBV+ (152.283) |
